Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug 5;2019:6175804.
doi: 10.1155/2019/6175804. eCollection 2019.

ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells

Affiliations
Free PMC article
Review

ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells

Anastasiya V Snezhkina et al. Oxid Med Cell Longev. .
Free PMC article

Abstract

Reactive oxygen species (ROS) are by-products of normal cell activity. They are produced in many cellular compartments and play a major role in signaling pathways. Overproduction of ROS is associated with the development of various human diseases (including cancer, cardiovascular, neurodegenerative, and metabolic disorders), inflammation, and aging. Tumors continuously generate ROS at increased levels that have a dual role in their development. Oxidative stress can promote tumor initiation, progression, and resistance to therapy through DNA damage, leading to the accumulation of mutations and genome instability, as well as reprogramming cell metabolism and signaling. On the contrary, elevated ROS levels can induce tumor cell death. This review covers the current data on the mechanisms of ROS generation and existing antioxidant systems balancing the redox state in mammalian cells that can also be related to tumors.

Conflict of interest statement

The authors declare that there is no conflict of interest regarding the publication of this paper.

Figures

Figure 1
Figure 1
Main sources of ROS production in normal and tumor cells.

Similar articles

See all similar articles

Cited by 6 articles

See all "Cited by" articles

References

    1. Zhang J., Wang X., Vikash V., et al. ROS and ROS-mediated cellular signaling. Oxidative Medicine and Cellular Longevity. 2016;2016:18. doi: 10.1155/2016/4350965.4350965 - DOI - PMC - PubMed
    1. Alfadda A. A., Sallam R. M. Reactive oxygen species in health and disease. Journal of Biomedicine and Biotechnology. 2012;2012:14. doi: 10.1155/2012/936486.936486 - DOI - PMC - PubMed
    1. Kudryavtseva A. V., Krasnov G. S., Dmitriev A. A., et al. Mitochondrial dysfunction and oxidative stress in aging and cancer. Oncotarget. 2016;7(29):44879–44905. doi: 10.18632/oncotarget.9821. - DOI - PMC - PubMed
    1. Storz P. Reactive oxygen species in tumor progression. Frontiers in Bioscience. 2005;10(1-3):1881–1896. doi: 10.2741/1667. - DOI - PubMed
    1. Dansen T. B., Wirtz K. W. The peroxisome in oxidative stress. IUBMB Life. 2001;51(4):223–230. - PubMed

MeSH terms

Feedback